Douglas Murphy-Chutorian | executive |
Renae Cormier | executive |
Jennifer Herrington | executive |
Brooks O'Neil | analyst |
Good afternoon, and welcome to the Semler Scientific's 2023 Fourth Quarter Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Before we begin, Semler Scientific needs to remind you that certain comments made during this call may constitute forward-looking statements and are made pursuant to and within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 as amended. These include statements regarding the expectations for expansion of the business and the development of marketing and additional products, including receipt and timing of an additional 510(k) clearance for QuantaFlo and investment in emerging growth opportunities. Such forward-looking statements are subject to both known and unknown risks and uncertainties that could cause actual results to differ materially from such statements. Those risks and uncertainties are described in the press release and our SEC filings.